These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 18439889)

  • 1. [How to realistically extend an access to renal replacement therapies in developing countries?].
    Jacobs C
    Nephrol Ther; 2008 Jul; 4(4):295-9. PubMed ID: 18439889
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug dosing adjustments during continuous renal replacement therapies.
    Golper TA; Marx MA
    Kidney Int Suppl; 1998 May; 66():S165-8. PubMed ID: 9573596
    [No Abstract]   [Full Text] [Related]  

  • 3. Continuous renal replacement therapies in patients with liver disease.
    Davenport A
    Semin Dial; 2009; 22(2):169-72. PubMed ID: 19426423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal replacement therapy in the developing world: are we on the right track, or should there be a new paradigm?
    Correa-Rotter R
    J Am Soc Nephrol; 2007 Jun; 18(6):1635-6. PubMed ID: 17494879
    [No Abstract]   [Full Text] [Related]  

  • 5. Circuit lifespan during continuous renal replacement therapy: children and adults are not equal.
    Ricci Z; Guzzo I; Picca S; Picardo S
    Crit Care; 2008; 12(5):178. PubMed ID: 18828884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous renal replacement technology: from adaptive technology and early dedicated machines towards flexible multipurpose machine platforms.
    Ricci Z; Bonello M; Salvatori G; Ratanarat R; Brendolan A; Dan M; Bellomo R; Ronco C
    Blood Purif; 2004; 22(3):269-76. PubMed ID: 15148455
    [No Abstract]   [Full Text] [Related]  

  • 7. Selection of modality of renal replacement therapy.
    Abi Antoun T; Palevsky PM
    Semin Dial; 2009; 22(2):108-13. PubMed ID: 19426412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute renal failure in the intensive care unit: which technique of renal replacement therapy?].
    Vincent JL; Piagnerelli M
    Rev Med Brux; 2008; 29(1 Suppl):S9-13. PubMed ID: 18497214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. End-stage renal disease in sub-Saharan Africa.
    Naicker S
    Ethn Dis; 2009; 19(1 Suppl 1):S1-13-5. PubMed ID: 19484867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular access for continuous renal replacement therapy.
    Vijayan A
    Semin Dial; 2009; 22(2):133-6. PubMed ID: 19426415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Field 7. Safety practice for renal-replacement therapies. French-speaking Society of Intensive Care. French Society of Anesthesia and Resuscitation].
    Journois D; Schortgen F
    Ann Fr Anesth Reanim; 2008 Oct; 27(10):e101-9. PubMed ID: 18950983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous renal replacement therapies in patients with acute neurological injury.
    Davenport A
    Semin Dial; 2009; 22(2):165-8. PubMed ID: 19426422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dialysis.
    McIntyre CW; Burton JO
    BMJ; 2014 Jan; 348():g2. PubMed ID: 24384463
    [No Abstract]   [Full Text] [Related]  

  • 14. Can inflammatory cytokines be removed efficiently by continuous renal replacement therapies?
    De Vriese AS; Vanholder RC; Pascual M; Lameire NH; Colardyn FA
    Intensive Care Med; 1999 Sep; 25(9):903-10. PubMed ID: 10501744
    [No Abstract]   [Full Text] [Related]  

  • 15. [Against CRRT: hybrid treatments are gaining ground].
    Basile C
    G Ital Nefrol; 2009; 26(1):22-5. PubMed ID: 19255960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers to a functional renal transplant program in developing countries.
    Bamgboye EL
    Ethn Dis; 2009; 19(1 Suppl 1):S1-56-9. PubMed ID: 19484877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous renal replacement therapy.
    Acierno MJ; Maeckelbergh V
    Compend Contin Educ Vet; 2008 May; 30(5):264-72. PubMed ID: 18581289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in developing evidence-based drug dosing guidelines for adults and children receiving renal replacement therapy.
    Mueller BA; Smoyer WE
    Clin Pharmacol Ther; 2009 Nov; 86(5):479-82. PubMed ID: 19844225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discontinuation of continuous renal replacement therapy: when is enough enough?
    Finkel KW; Podoll AS
    Crit Care Med; 2009 Sep; 37(9):2664-5. PubMed ID: 19687643
    [No Abstract]   [Full Text] [Related]  

  • 20. Modalities of continuous renal replacement therapy: technical and clinical considerations.
    Cerdá J; Ronco C
    Semin Dial; 2009; 22(2):114-22. PubMed ID: 19426413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.